Signal #144066 · SEC 8-K

$IOVA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $IOVA filing catalyst

Why did $IOVA trigger an AI stock catalyst alert?

$IOVA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Iovance Reports Q3 Revenue Surge to $122M, Net Loss Shrinks to -$0.05 per Share. Key points: - Total product revenue up ~80% YoY to ~$122M, driven by U.S. Amtagvi sales of ~$102M. - Net loss narrowed substantially to $(0.05) per share from $(0.25) in 3Q25; gross margin expanded to ~60%. - Full-year revenue guidance affirmed/updated at $410M to $420M with cash balance at $376M.

How did $IOVA stock react after the SEC filing?

After the SEC 8-K for $IOVA, observed market reaction: T0 price $8.70. Past moves do not guarantee future results.

Where can I get real-time $IOVA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $IOVA via Telegram and the VIP Web Terminal from €10/month.

$IOVA

$IOVA – Iovance Reports Q3 Revenue Surge to $122M, Net Loss Shrinks to -$0.05 per Share

IOVANCE BIOTHERAPEUTICS, INC.

2026-11-05 00:00:00 UTC · SEC 8-K · All $IOVA

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Total product revenue up ~80% YoY to ~$122M, driven by U.S. Amtagvi sales of ~$102M.
Net loss narrowed substantially to $(0.05) per share from $(0.25) in 3Q25; gross margin expanded to ~60%.
Full-year revenue guidance affirmed/updated at $410M to $420M with cash balance at $376M.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →